AMALY — SHARIAH COMPLIANCE REPORT
==================================
Symbol: GRAL
Report Date: 2026-09-22
Full Report: https://amaly.io/stock/GRAL

EXECUTIVE SUMMARY
------------------
Compliance Status: NON_COMPLIANT
Quality Rating: B
Description: GRAL, a biotechnology company specializing in cancer detection diagnostics, exhibits a mixed Shariah compliance profile. The core business is permissible under Islamic principles, promoting health and welfare. However, financial ratios reveal challenges, including high liquidity (40.04%) and interest income (18.79%), leading to non-compliance in major standards. Excluded from all Shariah indices, the stock is classified as NON_COMPLIANT overall, with a B quality rating. Purification of 18.79% is required for any permissible income.

Primary Compliance Concerns:
- High liquidity ratio of 40.04% exceeds thresholds across AAOIFI (30%), MSCI (33.33%), and S&P (33%)
- Interest income ratio of 18.79% surpasses the 5% impure income limit for all standards

Purification Requirement: 18.79%
Index Inclusion: Excluded from S&P Dow Jones Shariah Indices, MSCI Islamic Indices, FTSE Shariah Indices, and Dow Jones Islamic Market (DJIM)

KEY FINANCIAL METRICS
----------------------
Debt Ratio: 3.8%
Liquidity Ratio: 40.0%
Interest Income Ratio: 18.8%
Purification Required: 18.79%

INDEX INCLUSION STATUS
-----------------------
S&P Shariah: EXCLUDED
MSCI Islamic: EXCLUDED
DJIM: EXCLUDED
FTSE Shariah: EXCLUDED
Total: 0 of 4
Last Verified: 2025-12-31

REPORTING PERIOD
-----------------
Latest Annual Report: FY 2025
Latest Quarterly Data: Q4 2025
Trend Period: FY 2020 to FY 2025
Data Retrieved: 2026-02-21T00:00:00Z

---
Full interactive report: https://amaly.io/stock/GRAL
Provided by Amaly (https://amaly.io) — Shariah Compliant Stock Screener
Disclaimer: This data is for informational purposes only and does not constitute financial or religious advice.